SCHEMBL7149489

SCHEMBL7149489

COc1ccc(CNC(=O)c2ccc3[nH]c(=O)n(C(C)c4ccc(CC(=O)O)cc4)c(=O)c3c2)cc1.O=C(OCc1ccc2c(c1)OCO2)c1ccc2[nH]c(=O)n(Cc3ccccc3)c(=O)c2c1

nearest known ligand 0.60

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 2/20 0.60
MAPT P10636 10/20 0.47
ALDH1A1 P00352 5/20 0.44
KDM4E B2RXH2 3/20 0.44
HSD17B10 Q99714 3/20 0.44
HTT P42858 3/20 0.44
HPGD P15428 2/20 0.44
GAA P10253 5/20 0.43
TP53 P04637 3/20 0.43
SMN1; SMN2 Q16637 3/20 0.42
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
BACE1 P56817 1/20 0.42
GLA P06280 2/20 0.42
NPSR1 Q6W5P4 2/20 0.41
CACNA1G O43497 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6235392 0.82 MEN1 (0.54) ESR1MAPTALDH1A1KDM4EGAA
SCHEMBL6260663 0.80 ESR1 (0.56) ESR1MAPTALDH1A1KDM4EHSD17B10
SCHEMBL6245178 0.80 ESR1 (0.53) ESR1MAPTALDH1A1KDM4EHSD17B10
SCHEMBL6259249 0.78 KDM4E (0.55) ESR1MAPTALDH1A1KDM4EHSD17B10
SCHEMBL7624469 0.78 MEN1 (0.50) ESR1MAPTALDH1A1KDM4EHTT
SCHEMBL6471343 0.77 MAPT (0.75) ESR1MAPTALDH1A1KDM4EHSD17B10
SCHEMBL6218995 0.77 MEN1 (0.54) ESR1MAPTALDH1A1KDM4EGAA
SCHEMBL6239501 0.77 MEN1 (0.56) ESR1MAPTALDH1A1KDM4EGAA
SCHEMBL6466931 0.75 MEN1 (0.54) ESR1MAPTALDH1A1KDM4EGAA
SCHEMBL6464574 0.75 MEN1 (0.46) ESR1MAPTALDH1A1KDM4EGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1368324-A1 QUINAZOLINES AS MMP-13 INHIBITORS Warner-Lambert Company LLC (US) 2003-12-10 EP disclosed
WO-2002064572-A1 QUINAZOLINES AS MMP-13 INHIBITORS WARNER-LAMBERT COMPANY LLC (US) 2002-08-22 WO disclosed